These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12109035

  • 1. [Breast scintigraphy using 99mTc-sestamibi--use and limitations].
    Tiling R, Linke R, Kessler M, Untch M, Sommer H, Brinkbäumer K, Becker I, Hahn K.
    Nuklearmedizin; 2002 Jun; 41(3):148-56. PubMed ID: 12109035
    [Abstract] [Full Text] [Related]

  • 2. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E.
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
    Sommer H, Tiling R, Pechmann M, Kindermann G, Kress K, Moser R, Tatsch K, Hahn K, Pfluger T, Assemi C.
    Zentralbl Gynakol; 1997 Jan; 119(1):6-11. PubMed ID: 9050197
    [Abstract] [Full Text] [Related]

  • 4. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM, van der Zant FM, van Dongen A, Boer RO, Teule GJ, de Waard JW.
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [Abstract] [Full Text] [Related]

  • 5. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography.
    Tiling R, Kessler M, Untch M, Sommer H, Linke R, Hahn K.
    Eur J Radiol; 2005 Feb; 53(2):206-12. PubMed ID: 15664284
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
    Tiling R, Linke R, Untch M, Richter A, Fieber S, Brinkbäumer K, Tatsch K, Hahn K.
    Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
    [Abstract] [Full Text] [Related]

  • 7. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Prats E, Aisa F, Abós MD, Villavieja L, García-López F, Asenjo MJ, Razola P, Banzo J.
    J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
    [Abstract] [Full Text] [Related]

  • 8. Technetium-99m sestamibi in the diagnosis of breast cancer. The Mayagüez Medical Center experience.
    Farías-Jimenez J, Rivera A, Carlo VM.
    Bol Asoc Med P R; 2001 Feb; 93(1-12):9-11. PubMed ID: 12755069
    [Abstract] [Full Text] [Related]

  • 9. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
    Bekiş R, Derebek E, Balci P, Koçdor MA, Değirmenci B, Canda T, Durak H.
    Nuklearmedizin; 2004 Feb; 43(1):16-20. PubMed ID: 14978536
    [Abstract] [Full Text] [Related]

  • 10. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
    Prats E, Carril J, Herranz R, Meroño E, Banzo J, Gtemegmmt YE.
    Rev Esp Med Nucl; 1998 Feb; 17(5):338-50. PubMed ID: 9812008
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions.
    Tiling R, Sommer H, Pechmann M, Moser R, Kress K, Pfluger T, Tatsch K, Hahn K.
    J Nucl Med; 1997 Jan; 38(1):58-62. PubMed ID: 8998151
    [Abstract] [Full Text] [Related]

  • 16. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
    Mulero F, Nicolás F, Castellón MI, Fuentes T, de la Cruz P, Roca V, Abad L, Nuño de La Rosa JA.
    Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
    [Abstract] [Full Text] [Related]

  • 17. Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography.
    Tiling R, Khalkhali I, Sommer H, Linke R, Moser R, Willemsen F, Pfluger T, Tatsch K, Hahn K.
    Nucl Med Commun; 1998 Jan; 19(1):55-62. PubMed ID: 9515547
    [Abstract] [Full Text] [Related]

  • 18. Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma.
    Howarth D, Sillar R, Clark D, Lan L.
    Eur J Nucl Med; 1999 Nov; 26(11):1475-81. PubMed ID: 10552090
    [Abstract] [Full Text] [Related]

  • 19. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
    Lumachi F, Zucchetta P, Marzola MC, Ferretti G, Povolato M, Paris MK, Brandes AA, Bui F.
    Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
    [Abstract] [Full Text] [Related]

  • 20. Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
    Tiling R, Kessler M, Untch M, Sommer H, Linke R, Brinkbäumer K, Hahn K.
    Onkologie; 2003 Feb; 26(1):27-31. PubMed ID: 12624514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.